The PE Ratio as of December 2025 (TTM) for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is 10.64

According to Genomma Lab Internacional, S.A.B. de C.V.’s latest financial reports and current stock price. The company's current PE Ratio is 10.64. This represents a change of -11.43% compared to the average of 12.01 of the last 4 quarters.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Historical PE Ratio (quarterly & annually)

How has GNMLF PE Ratio performed in the past?

The mean historical PE Ratio of Genomma Lab Internacional, S.A.B. de C.V. over the last ten years is 9.64. The current 10.64 PE Ratio has changed 10.94% with respect to the historical average. Over the past ten years (40 quarters), GNMLF's PE Ratio was at its highest in in the December 2016 quarter at 269.00. The PE Ratio was at its lowest in in the December 2023 quarter at -55.07.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Genomma Lab Internacional, S.A.B. de C.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Average PE Ratio

How has GNMLF PE Ratio performed in the past?

The current PE Ratio of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) PE Ratio vs. Peers

How is GNMLF’s PE Ratio compared to its peers?

Genomma Lab Internacional, S.A.B. de C.V.’s PE Ratio is less than SSY Group Limited (13.87), less than Safilo Group S.p.A. (17.26), less than Netcare Limited (12.48), greater than Towa Pharmaceutical Co., Ltd. (10.27), less than BioGaia AB (publ) (31.56), less than Kissei Pharmaceutical Co., Ltd. (15.20), less than Rhoen-Klinikum AG (23.24), less than Extendicare Inc. (22.42), less than Tong Ren Tang Technologies Co. Ltd. (12.72), less than RHON-KLINIKUM AG Unsponsored ADR (23.24),

Build a custom stock screener for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomma Lab Internacional, S.A.B. de C.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genomma Lab Internacional, S.A.B. de C.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.